Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs James Hardie Industries plc. Ordinary Shares (JHX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs James Hardie Industries plc. Ordinary Shares — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while James Hardie Industries plc. Ordinary Shares trades at $25.06 (market cap $14.60B). The key difference: James Hardie Industries plc. Ordinary Shares is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, James Hardie Industries plc. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and James Hardie Industries plc. Ordinary Shares for 1 Days on average.
| HALO | JHX | |
|---|---|---|
Market Cap | $12.58B | $14.60B |
Volume | 2,179,278 | 7,262,924 |
Sector | Health | Basic Materials |
52-Week High | $115.22 | $31.08 |
52-Week Low | $61.63 | $16.69 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $18.83B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About James Hardie Industries plc. Ordinary Shares
James Hardie manufactures fiber cement products for residential and commercial construction. Its portfolio includes exterior siding, interior boards, and other building materials.
Read more on JHX →
